Journal of Crohns & Colitis

Journal Abbreviation: J CROHNS COLITIS
ISSN: 1873-9946
Publisher: Elsevier

Publications (73)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Upadacitinib improves steroid-free clinical and endoscopic endpoints in patients with Crohn's disease: Data from the CELEST study (2018) Panaccione R, Atreya R, Ferrante M, Dubinsky MC, Sands BE, Abreu MT, Cataldi F, et al. Conference contribution Luminal application of a GATA3-specific DNAzyme ameliorates mucosal inflammation in a randomised trial with active ulcerative colitis patients (2018) Atreya R, Kuehbacher T, Schmitt H, Hirschmann S, Waldner M, Drvarov O, Fischer SM, et al. Conference contribution Rifaximin and Saccharomyces boulardii increase stress resilience in TNBS-induced colitis (2018) Konturek P, Zopf Y, Dieterich W, Wirtz S, Neurath M, Brzozowski T Conference contribution Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY (2018) Bossuyt P, Atreya R, Taxonera C, Hebuterne X, Isaacs K, Higgins PD, Lindsay J, et al. Conference contribution IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn's disease patients (2018) Schmitt H, Billmeier U, Dieterich W, Rath T, Sonnewald S, Reid S, Hirschmann S, et al. Conference contribution Hobit- and Blimp1-driven tissue resident memory T cells critically control chronic intestinal inflammation (2018) Zundler S, Becker E, Spocinska M, Parga-Vidal L, Stark R, Atreya R, Rath T, et al. Conference contribution IL-3 drives IL-10-secreting Tr1 cells to counteract experimental colitis (2018) Zundler S, Spocinska M, Popp V, Becker E, Atreya R, Neufert C, Atreya I, et al. Conference contribution Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease (2018) Koelink PJ, Wildenberg ME, Stitt LW, Feagan BG, Koldijk M, Van 'T Wout AB, Atreya R, et al. Journal article Clinical outcomes and immunogenicity analysis over 6 months following a switch from originator infliximab (Remicade (R)) to the biosimilar SB2 (Flixabi (R)) in inflammatory bowel disease patients (2018) Fischer SM, Klenske E, Schmitt H, Vitali F, Hirschmann S, Koch F, Ramming A, et al. Conference contribution Alpha 4 beta 7 Integrin-dependent gut homing of non-classical monocytes is essential for intestinal wound healing mediated by M2 macrophages (2018) Schleier L, Wiendl M, Binder MT, Atreya R, Watson A, Neufert C, Atreya I, et al. Conference contribution
1 ... 4 5 6 7 8